NRAS and melanoma: The two cell lines which were the least sensitive to the growth inhibitory effect of pazopanib, were the melanoma cell lines: SKMEL2 that expresses mutant N-Ras and the SKMEL28 line that harbors the V600E mutation for B-Raf (IC50 5.13 and 6.13 μM, respectively).